Our bodies produce an appetite-regulating hormone called glucagon-like peptide 1 (GLP-1), which helps limit our hunger, keeps us satiated and helps control nagging cravings often referred to as food noise
BPC-157 is a synthetic peptide derived from a naturally occurring body protection compound
The lethal dose in humans would be approximately 21,000mg for a 70kg person, making the 1-3mg daily doses used in typical protocols extremely safe from a toxicity standpoint
Comprehensive documentation of treatment rationale, patient consent processes, and clinical monitoring should be maintained given the experimental nature of these interventions and potential regulatory scrutiny
Reimbursement Rates by Payer Type Medicare reimburses J1071 at approximately $0.04-0.06 per unit based on the Average Sales Price (ASP) methodology updated quarterly
Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation
